Research-backed strains for mood elevation and emotional healing
Psilocybin-assisted therapy has shown promise for treatment-resistant depression in controlled settings with professional support. Strain choice, set and setting, and integration matter for outcomes. For the full clinical evidence, see our Psilocybin Therapy Guide below.
Strains that support introspective, emotionally opening experiences are often preferred for mood-related goals. We focus on strain selection and harm reduction; professional support and integration are essential.
Dosage is crucial for achieving your desired outcome. Here are general recommendations for depression:
2g - 3.5g
Moderate to full dose for meaningful emotional work
With guide
Best done with a trained facilitator or therapist
Psilocybin is not a substitute for professional mental health treatment
If experiencing severe depression or suicidal thoughts, seek professional help immediately
Psilocybin can intensify emotions — professional support during and after is essential
Do not discontinue prescribed medications without consulting your doctor
Integration therapy with a mental health professional is strongly recommended
Those with personal or family history of psychosis should avoid psilocybin
Professional Guidance Recommended
For depression-related use, we strongly recommend working with a qualified mental health professional who can provide proper screening, preparation, support during the experience, and integration therapy afterward. The research showing benefits was conducted in controlled clinical settings with professional support.
No. Psilocybin-for-depression studies (e.g. Johns Hopkins, Imperial College London) were done in controlled clinical settings with professional support, not as a replacement for prescribed medications. Never discontinue psychiatric medications without your prescribing physician's guidance. Psilocybin is not currently approved for this use.
Clinical trials involve extensive preparation sessions, carefully controlled dosing, professional psychological support during the experience, and follow-up integration therapy. This structured approach appears to be crucial for therapeutic outcomes. Self-administration without this support structure may not produce the same benefits and carries additional risks.
Clinical trials (Johns Hopkins, Imperial College London) used controlled settings with screening and support; in those conditions psilocybin was generally safe. Psilocybin can intensify emotions and may not be appropriate for everyone. Those with bipolar disorder, psychosis history, or certain other conditions may face elevated risks. Professional guidance is strongly recommended.
Get comprehensive information about preparation, safety, and integration in our detailed guide.
Psilocybin Therapy GuideOne of our best strains — potent, mood-elevating, and highly regarded by members; excellent for supported emotional work.
View Strain DetailsNamed for its tendency to produce insightful, teaching experiences that can shift perspective.
View Strain DetailsHigh potency enables profound experiences at lower doses; often used in therapeutic settings.
View Strain DetailsGentle euphoria and emotional warmth without overwhelming intensity.
View Strain DetailsThis information is for educational purposes only and is not intended as medical advice, diagnosis, or treatment for depression or any other condition. Psilocybin is not FDA-approved for treating depression. If you are experiencing depression, please consult with a qualified mental health professional. If you are having thoughts of self-harm, contact the National Suicide Prevention Lifeline at 988 or your local emergency services.
If you are experiencing a mental health crisis, please contact the National Suicide Prevention Lifeline at 988 or your local emergency services.